U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07343102) titled 'Incidence of Hemocompatibility Events With or Without Aspirin in Patients With CH-VAD' on Nov. 26, 2025.
Brief Summary: The goal of this observational study is to investigate the impact of oral warfarin anticoagulation combined with or without aspirin on the incidence of non-surgical hemocompatibility-related adverse events (HRAEs) and survival in advanced heart failure patients after implantation of the fully magnetic levitation left ventricular assist device (CH-VAD).
The main question it aims to answer is : The incidence of non-surgical HRAEs and survival treated with oral warfarin anticoagulation combined with or without aspiri...